Updated Jul 16, 2026
DEAN JACK H has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
According to the SEC filing context provided, Jack H. Dean serves as a director of Acurx Pharmaceuticals, Inc. The most recent SEC filing dated 2026-04-22 lists him in the role of Director. No additional public biographical details are available in the provided context.
| Role | Director |
|---|---|
| Notability | 20/100 |
According to the SEC filing context provided, Jack H. Dean serves as a director of Acurx Pharmaceuticals, Inc. The most recent SEC filing dated 2026-04-22 lists him in the role of Director. No additional public biographical details are available in the provided context.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live DEAN JACK H profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.